PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation

Background & Aims: Phosphatidylinositides-3 kinases (PI3Ks) are promising drug targets for cancer therapy, but blockage of PI3K-AKT signalling causes hyperglycaemia, hyperinsulinaemia, and liver damage in patients, and hepatocellular carcinoma (HCC) in mice. There are 4 PI3Ks: PI3Kα, PI3Kβ,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Barbara Becattini, Ludovic Breasson, Claudia Sardi, Fabio Zani, Giovanni Solinas
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
AKT
Acceso en línea:https://doaj.org/article/0fe2adb7ba684bfba3441a0071b78ab9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares